We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hamburg: Clinical Trials at Core of New Regulatory Science
Hamburg: Clinical Trials at Core of New Regulatory Science
September 30, 2009
In calling for a new form of regulatory science to keep up with emerging technologies, FDA Commissioner Margaret Hamburg emphasized the importance of clinical research in reaching that goal.